SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 226 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.86 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,214,238 | -19.2% | 44,042 | -11.9% | 0.00% | 0.0% |
| Q2 2023 | $1,502,790 | -14.1% | 49,993 | +3.5% | 0.00% | -20.0% |
| Q1 2023 | $1,750,308 | -8.6% | 48,311 | -10.0% | 0.01% | -16.7% |
| Q4 2022 | $1,914,445 | +4.4% | 53,671 | -0.9% | 0.01% | 0.0% |
| Q3 2022 | $1,833,000 | +9.8% | 54,151 | -6.1% | 0.01% | +50.0% |
| Q2 2022 | $1,669,000 | -25.8% | 57,696 | -17.1% | 0.00% | -20.0% |
| Q1 2022 | $2,249,000 | +10.8% | 69,600 | 0.0% | 0.01% | +25.0% |
| Q4 2021 | $2,030,000 | +9.4% | 69,600 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $1,856,000 | -13.4% | 69,600 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $2,143,000 | +17.6% | 69,600 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $1,822,000 | +4.1% | 69,600 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $1,751,000 | +7.3% | 69,600 | -11.1% | 0.00% | 0.0% |
| Q3 2020 | $1,632,000 | -12.4% | 78,300 | -0.1% | 0.00% | -20.0% |
| Q2 2020 | $1,862,000 | +26.1% | 78,400 | -4.5% | 0.01% | 0.0% |
| Q1 2020 | $1,477,000 | -15.7% | 82,100 | +11.1% | 0.01% | +25.0% |
| Q4 2019 | $1,753,000 | -13.7% | 73,900 | 0.0% | 0.00% | -33.3% |
| Q3 2019 | $2,031,000 | +164.5% | 73,900 | +218.5% | 0.01% | +200.0% |
| Q2 2019 | $768,000 | -66.4% | 23,200 | -64.4% | 0.00% | -66.7% |
| Q1 2019 | $2,285,000 | +36.7% | 65,200 | +29.6% | 0.01% | +20.0% |
| Q4 2018 | $1,671,000 | -33.5% | 50,300 | +0.8% | 0.01% | -28.6% |
| Q3 2018 | $2,512,000 | -15.9% | 49,900 | 0.0% | 0.01% | -22.2% |
| Q2 2018 | $2,987,000 | +37.3% | 49,900 | +5.1% | 0.01% | +50.0% |
| Q1 2018 | $2,175,000 | +14.9% | 47,500 | 0.0% | 0.01% | +20.0% |
| Q4 2017 | $1,893,000 | +31.5% | 47,500 | +31.9% | 0.01% | +25.0% |
| Q3 2017 | $1,440,000 | -7.2% | 36,000 | 0.0% | 0.00% | -20.0% |
| Q2 2017 | $1,552,000 | – | 36,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ASHFORD CAPITAL MANAGEMENT INC | 921,962 | $33,402,683 | 5.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 423,500 | $15,326,465 | 4.28% |
| ARMISTICE CAPITAL, LLC | 4,350,000 | $157,600,500 | 2.27% |
| S&T BANK/PA | 223,775 | $8,107 | 1.46% |
| Aristotle Capital Boston, LLC | 1,155,149 | $41,851,071 | 1.29% |
| Tributary Capital Management, LLC | 353,671 | $12,813,500 | 1.19% |
| Bridge City Capital, LLC | 62,790 | $2,274,882 | 1.14% |
| RICE HALL JAMES & ASSOCIATES, LLC | 551,285 | $19,973,056 | 1.14% |
| Intrinsic Edge Capital Management LLC | 289,704 | $10,495,976 | 1.05% |
| Parkman Healthcare Partners LLC | 131,878 | $4,777,940 | 1.04% |